Antibiotic therapy and cystic fibrosis: increased resistance of mucoid Pseudomonas aeruginosa to carbenicillin.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002228:Carbenicillin / Q000494:pharmacology*; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D010403:Penicillin Resistance; D011550:Pseudomonas aeruginosa / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D002228:Carbenicillin